BRPI0621552A2 - tratamentos antivirais intramusculares - Google Patents

tratamentos antivirais intramusculares Download PDF

Info

Publication number
BRPI0621552A2
BRPI0621552A2 BRPI0621552-1A BRPI0621552A BRPI0621552A2 BR PI0621552 A2 BRPI0621552 A2 BR PI0621552A2 BR PI0621552 A BRPI0621552 A BR PI0621552A BR PI0621552 A2 BRPI0621552 A2 BR PI0621552A2
Authority
BR
Brazil
Prior art keywords
formula
compound
pharmaceutically acceptable
acceptable salt
use according
Prior art date
Application number
BRPI0621552-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Yarlagadda S Babu
Pooran Chand
Shanta Bantia
Shane Arnold
John Michael Kilpatrick
Original Assignee
Biocryst Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocryst Pharm Inc filed Critical Biocryst Pharm Inc
Publication of BRPI0621552A2 publication Critical patent/BRPI0621552A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
BRPI0621552-1A 2006-04-12 2006-04-12 tratamentos antivirais intramusculares BRPI0621552A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/013535 WO2007117241A1 (en) 2006-04-12 2006-04-12 Intramuscular antiviral treatments

Publications (1)

Publication Number Publication Date
BRPI0621552A2 true BRPI0621552A2 (pt) 2011-12-13

Family

ID=37671157

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0621552-1A BRPI0621552A2 (pt) 2006-04-12 2006-04-12 tratamentos antivirais intramusculares

Country Status (8)

Country Link
JP (1) JP2009533428A (ru)
CN (1) CN104784166A (ru)
AU (1) AU2006341592A1 (ru)
BR (1) BRPI0621552A2 (ru)
CA (1) CA2649090A1 (ru)
EA (1) EA200870430A1 (ru)
MX (1) MX2008013140A (ru)
WO (1) WO2007117241A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0518443D0 (en) 2005-09-09 2005-10-19 Evolutec Ltd Method of treating myasthenia gravis
CN101367750B (zh) * 2007-08-14 2012-05-23 中国人民解放军军事医学科学院毒物药物研究所 (1s,2s,3s,4r)-3-[(1s)-1-乙酰氨-2-乙基-丁基]-4-胍基-2-羟基-环戊基-1-羧酸水合物及其医药用途
AU2011204483B2 (en) * 2010-01-08 2016-02-11 Volution Immuno Pharmaceuticals Sa EV576 for use in the treatment of viral infections of the respiratory tract
CN102584637B (zh) * 2011-01-17 2014-07-09 天津药物研究院 帕拉米韦水合物晶体、制备方法、药用组合物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1282316A (zh) * 1997-12-17 2001-01-31 生物晶体药品股份有限公司 用作神经氨酸酶抑制剂的取代环戊烷和环戊烯化合物
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments

Also Published As

Publication number Publication date
EA200870430A1 (ru) 2009-06-30
WO2007117241A1 (en) 2007-10-18
AU2006341592A1 (en) 2007-10-18
MX2008013140A (es) 2009-02-12
CN104784166A (zh) 2015-07-22
JP2009533428A (ja) 2009-09-17
CA2649090A1 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
WO2009021404A1 (fr) Hydrates d'acide (1s, 2s, 3s, 4r)-3-[(1s)-1-acétylamino-2-éthylbutyl]-4-guanidino-2-hydroxylcyclopentyl-1-carboxylique et leurs utilisations pharmaceutiques
US20080125400A1 (en) Use of phosphoenolpyruvate derivatives
BRPI0621552A2 (pt) tratamentos antivirais intramusculares
JP6198741B2 (ja) インフルエンザを処置するための化合物
JP7460772B2 (ja) コロナウイルス感染症の治療方法
ES2622372T3 (es) Composición de enema para tratamiento de la colitis ulcerosa que tiene estabilidad a largo plazo
JP6073202B2 (ja) 静脈におけるウイルスの治療
ES2617235T3 (es) Uso de pidotimod para tratar psoriasis
US20070244193A1 (en) Intramuscular antiviral treatments
JPS6342603B2 (ru)
KR20080113099A (ko) 근육내 항바이러스 치료
ES2289305T3 (es) Medicamento para el tratamiento del "sindrome de la respuesta inflamatoria sistemica".
CA3213365A1 (en) Prevention and treatment of coronavirus infection
US20230151034A1 (en) Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
AU2016262644A1 (en) Intravenous antiviral treatments

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A ANUIDADE

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2214 DE 11/06/2013.